IR Zen

HONG KONG, Nov 3, 2023 - (ACN Newswire via SeaPRwire.com) - The 31st Hong Kong Optical Fair, organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong Optical Manufacturers Association (HKOMA), will return to the Hong Kong Convention and Exhibition Centre (HKCEC) as a physical exhibition for the first time since 2019. The physical event will run from 8 to 10 November under the EXHIBITION+ integrated physical-online mode, when about 700 exhibitors from 11 countries and regions will present the latest eyewear designs and products.Regional pavilions will include Mainland China, Taiwan, Italy, Japan and Korea, and two special sections – Visionaries of Style and the HKOMA pavilion. The fair also has multiple themed exhibition areas to facilitate buyers’ purchasing.Showcasing the latest technological innovations in optical wear, this year’s Optical Fair will feature a Smart Eyewear zone. Hong Kong exhibitor Solos Technology Limited will display smart glasses that combine ChatGPT and wearable technology AirGo™3. Hong Kong firm 3DNA Technology Limited uses software with 360-degree facial scanning technology to help customers tailor-make suitable glasses. Other themed zones will present professional eyewear, eyewear accessories, frames, lenses, contact lenses, diagnostic instruments, optical instruments and more.The Brand Name Gallery, a focal point of the fair, features about 200 brands from around the world, including Hong Kong s A.Society, Absolute Vintage Eyewear, bTd, Taiwan’s CLASSICO, PARIM, reputable international brands such as agnès b and MINIMA from France; Anna Sui, Jill Stuart, New Balance, and VOY from the United States; Ted Baker and Vivienne Westwood from the United Kingdom; STEPPER from Germany; Japan’s Masaki Matsushima, Matsuda, MIZ Gold, TiDOU, and Korea’s GENSDUMONDE, PEOPLE LUV ME and PLUME. The fair will also feature eyewear shows, where professional models will showcase fashion eyewear trends from various places.HKTDC Deputy Executive Director Sophia Chong, said: “The Hong Kong Optical Fair is back at the HKCEC. We are very pleased to welcome many new international brands from all over the world this year, including the fashion capitals of France, the United Kingdom, the United States and Italy, as well as Asian trendsetters from such places as Japan, Korea and Taiwan. The fair has incorporated many international elements while keeping up with the world’s trends, demonstrating the reputation of Hong Kong as the capital of international exhibitions.”The Optical Fair brings together the latest products from well-known exhibitors and new technologies related to eyewear. There is also a series of product promotions, conferences, seminars where visitors can find out about the latest developments in the optical industry. An award presentation ceremony for the Eyewear Design Competition will also be held during the fair. A media guided tour will be held on the first day of the fair to give the media a first-hand look at the highlights of selected exhibitors’ products and services.We cordially invite you or your representative to cover the fair, media tour and kick-off session of the 21st Hong Kong International Optometric Symposium and related events. Details of key events are as follows:Fair Details (Physical)Date: 8 to 10 November (Wednesday to Friday)Time: (8 to 9 November) 9:30am – 6:30pm (10 November) 9:30am – 5pmVenue: Hong Kong Convention and Exhibition CentreAdmission: For trade visitors aged 18 or above only.Onsite Registration Fee: HK$100 per person (Free for e-Badge registration and pre-registered buyers)Click2Match (Smart business-matching platform) Date: 1 to 17 NovemberMedia TourDate: 8 November 2023 (Wednesday)Time: 2pm - 3pmVenue: Meet at 1:45pm at HKTDC SME Centre, G/F, Expo Drive Entrance, HKCECHost: May Wong, Section Head, Business Development, HKTDCNote:Press members can register to access the event at the Press Registration Counter (Hall 1D Concourse, HKCEC) by presenting a business card or media identification.[Highlighted events]8 November (Wednesday)Award Presentation Ceremony for the 23rd Hong Kong Eyewear Design Competition:  Organised by the HKTDC and the HKOMA, and co-organised by the Hong Kong Polytechnic University and the Hong Kong Institute of Vocational Education, the event aims to encourage and enhance the design standard of Hong Kong's eyewear manufacturing industry and promote creativity in product design and style, so as to strengthen the interest of the younger generation in eyewear design.Networking Reception: The reception promotes business discussions among industry insiders, with Dr Lo Kam-wing, Council Member of the HKTDC, serving as the officiating guest.9 November (Thursday)The 21st Hong Kong International Optometric Symposium: Jointly organised by the HKTDC, the Hong Kong Optometric Association and the Hong Kong Polytechnic University under the theme Empowering Community Eye Care through Artificial Intelligence and Telemedicine in Optometry, the symposium will see Dr Simon Tang, Director of Cluster Services of the Hospital Authority, will deliver the opening speech. A number of industry experts from around the world will explore the application of AI in optometry, the impact of telemedicine on healthcare and how it can be effectively applied to community eye care.Seminar: Market Talk – Road Ahead for Eyewear Industry: Industry experts will discuss the latest fashion trends forecast and sustainability elements in the United States eyewear sector. Speakers will also explore the digitalisation of supply chain in the industry and its impact on manufacturing and retail, as well as the latest market outlook and potential of smart eyewear.Seminar: Revolutionising Eyewear Design – Exploring 3D Technologies, Innovations and Material Trends: Technological advancements continue to drive revolutionary development in eyewear design, including the latest 3D technologies, innovative design and materials trends. Experts will uncover the most important innovative trends in eyewear design that you must know.10 November (Friday)Seminar: Latest Developments in Standardisation for Optometry in Mainland China: Experts will explain the latest technical specifications and testing guidelines for myopia prevention and control glasses, lenses, smart glasses and other optometry products for teenagers in Mainland China, allowing industry insiders to grasp the latest developments in the mainland's optometry product market.[Featured Exhibitors]The Optical Fair will showcase a variety of eyewear with innovative technologies as well as new products and services. Some of the featured exhibitors include:360-degree scanning of the face for a personalised and fully customizable glasses experienceLocal company 3DNA Eyewear will showcase its self-developed interactive eyewear customisation platform that can offer innovative and engaging eyewear retail experience. The kiosk format for retailers features backlit shelving, pull out frame drawers, 200 pieces of  swatch display, adjustable 3D scanner mirror, and three high-definition monitors.The machine will scan and measure customer facial features through computer software, then display a 3D avatar on the screen. Customers can tailor-make their own glasses with their personal style from a selection of more than 2,000 designs, with choices ranging from materials, patterns and colours to bespoke features such as narrow frames and printed names. The simulated design will be displayed on the monitor immediately.Global retailers and suppliers are connected through the 3DNA open platform. then the final order will be sent directly to the production factories in mainland China, the United States, or the United Kingdom.3DNA Technology Limited - Booth: 1CON-046ChatGPT Smart  EyewearFirst-time Hong Kong exhibitor Solos Technology Limited will feature the latest collection AirGo™ 3, smart glasses which combine ChatGPT with wearable tech.Users can press and hold an action button on the smart glasses’ temple to ask ChatGPT a question. They will see the reply through the lenses and also hear the answer. SolosTranslate is another ChatGPT-supported service, a live language translation with the power of voice. The nine supported languages include Cantonese, French, Japanese, Korean, Mandarin and Spanish. AirGo™ 3 was officially released in SILMO in September this year with more than 100 patents.Solos Technology Limited - Booth: GH-B38More innovative and environmental eyewear can be found in the below selected exhibitors list:  https://bit.ly/3QeVugeWebsitesHong Kong Optical Fair:  https://www.hktdc.com/event/hkopticalfair/tcHong Kong Optical Fair event details: https://www.hktdc.com/event/hkopticalfair/en/intelligence-hubThe 21st Hong Kong International Optometric Symposium: https://www.hktdc.com/event/hkopticalfair/tc/the-21st-hong-kong-international-optometric-symposiumHKTDC Media Room: http://mediaroom.hktdc.com/enMedia enquiriesPlease contact the HKTDC’s Communication and Public Affairs Department:Frankie Leung, Tel: (852) 2584 4298, Email: frankie.cy.leung@hktdc.orgPhyllis Tsang, Tel: (852) 2584 4288, Email: phyllis.km.tsang@hktdc.org Copyright 2023 ACN Newswire via SeaPRwire.com.

BANGKOK, Nov 2, 2023 - (ACN Newswire via SeaPRwire.com) - SAFE Fertility Group Plc, or SAFE, a comprehensive fertility clinic operator, made its debut on the Stock Exchange of Thailand (SET). The company has a strategy to build on its strengths in fertility treatment to achieve sustainable growth and become a leader in fertility treatment, genetic diagnosis of embryos, and wellness in Asia. In the first half of this year, the company reported strong earnings with net profit of over THB 87 million.Dr. Wiwat Quangkananurug, a medical specialist in fertility treatment with assisted reproductive technology, as the Chief Executive Officer of SAFE, reported that the company's shares were listed on the SET on November 2, 2023, under the service industry. This was after the company successfully offered 76,748,600 new shares to the public for the first time (IPO) at THB 21 per share. This is a major step for SAFE to support the company's plans to expand its fertility treatment services and genetic laboratories to be more comprehensive. This will help fulfill the dreams of infertile people to have the opportunity to have the children they desire. SAFE will also help drive Thailand to be a destination for infertile people from around the world (Fertility Tourism), in line with the government's policy to develop Thailand into an international health hub to drive the economy in the future.In addition, the company has a strategy to drive the business to become a leader in fertility treatment, genetic diagnosis of embryos, and wellness in Asia. This will be achieved through the expansion of fertility clinics and fertility laboratories to partner hospitals with a nationwide network or to partner healthcare facilities in locations with economic and tourism potential. This will be done through commercial partnerships, joint ventures, and mergers and acquisitions. The company will also use modern and effective treatment technologies and continuously develop its service staff to promote its leadership. In addition, the company will communicate and build the “SAFE FERTILITY” brand as a leader in fertility treatment and embryo genetic diagnosis in Asia in a more aggressive way, such as through offline and online channels to consumers in Thailand and abroad, and through digital marketing. The company also plans to expand into other related businesses.SAFE plans to use the proceeds from the fundraising to create sustainable growth potential in the future. In the near term, the company will relocate its Ramindra branch to a space in the Golf Channel Center golf driving range project on Ramindra Road. This will make it more convenient for customers and provide more comprehensive services, such as a modern and spacious genetics laboratory for the company's scientists. The company expects to invest approximately THB 100 million in this project. The company is also considering the opportunity to invest in laboratories in private and government hospitals, and to partner with private hospitals in Thailand and abroad in the form of joint ventures.The company's operating results for the years 2023-2025 were THB 529.77 million, THB 561.96 million, and THB 729.32 million, respectively. The net profit for the same periods was THB 42.16 million, THB 78.23 million, and THB 161.73 million, respectively. For the first six months of 2023, the company had total revenue of THB 409.84 million, an increase of 9.4% from the same period of the previous year. The net profit was THB 87.4 million, a decrease of 3.89% from the same period of the previous year. The slight decrease in net profit was due to expenses incurred in preparation for the company's listing on the stock exchange, which are one-time expenses.“We are confident that SAFE will grow by leaps and bounds from its strong financial foundation and become a leader in fertility treatment, embryo genetic diagnosis, and wellness in Asia. We will help fulfill the dreams of infertile people by focusing on providing world-class services that are committed to patient safety with innovative and modern technologies,” said the CEO of SAFE.Darin Kanjana, CEO of Optasia Capital, as the financial advisor, said that SAFE is a company with high business growth potential in the overall global fertility treatment market, which is growing significantly. It will be a Growth Stock that will generate good returns for investors. This is due to the company's distinctive business model, which is mutually beneficial and will drive the company's sustainable growth. The company also provides integrated full-service for fertility clinics that are certified to meet international standards for reproductive services.She added that the company has 5 branches in key locations, has good relationships with hospitals, obstetrics and gynecology clinics, fertility centers, etc., and is well-known for treating infertile foreigners from countries such as China, India, Myanmar, Vietnam, Singapore, and Japan.Pichet Sitthi-Amnuai, CEO of Bualuang Securities, as the underwriter, said that the IPO offering of SAFE was a total of 76.75 million shares at a price of THB 21 per share, with a total offering value of THB 1,611.72 million. It was well-received by both leading institutional investors and retail investors. This is because investors are confident in the business potential of SAFE, which is a leader in fertility treatment and is in an industry with high growth potential. The investors are also confident that the fundraising will strengthen the company's financial position to expand its business as planned.Furthermore, SAFE is committed to social activities. The company will consider the interests of stakeholders in various dimensions, including the company, employees, customers, the public, society, and various organizations. The company has projects to donate money to schools in need, donate medical equipment to hospitals, and donate THB 100 of service fees for every Qualify test to charity. Mr. Pichet is confident that SAFE will be a quality stock in the Thai capital market.Visit: https://www.safefertilitygroup.com/en/home (SET: SAFE; SET: SAFE-R; SET: SAFE/F)This press release is distributed by MT Multimedia Co., Ltd. for SAFE Fertility Group Pcl.Please contact: Wasana Wongsiri (Jeab), Tel: +66 84-359-0659 or +66 2-612-2081 x131, Email: wasana.w@mtmultimedia.co Copyright 2023 ACN Newswire via SeaPRwire.com.